2022 Q1 Form 10-Q Financial Statement

#000143774922010537 Filed on May 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $31.34M $35.06M
YoY Change -10.62% -293.38%
Cost Of Revenue $9.959M $7.830M
YoY Change 27.19% 96.24%
Gross Profit $21.38M $27.23M
YoY Change -21.49% -223.16%
Gross Profit Margin 68.22% 77.67%
Selling, General & Admin $2.491M $2.040M
YoY Change 22.11% 277.78%
% of Gross Profit 11.65% 7.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $944.0K $0.00
YoY Change
% of Gross Profit 4.42% 0.0%
Operating Expenses $3.632M $3.372M
YoY Change 7.71% 181.23%
Operating Profit $17.75M $23.86M
YoY Change -25.61% -202.36%
Interest Expense $8.818M $6.497M
YoY Change 35.72% 95.05%
% of Operating Profit 49.69% 27.23%
Other Income/Expense, Net -$786.0K $22.29M
YoY Change -103.53% -189.43%
Pretax Income $18.74M $25.07M
YoY Change -25.26% -209.62%
Income Tax
% Of Pretax Income
Net Earnings $18.74M $25.07M
YoY Change -25.26% -494.62%
Net Earnings / Revenue 59.79% 71.51%
Basic Earnings Per Share $0.93 $1.67
Diluted Earnings Per Share $0.81 $1.26
COMMON SHARES
Basic Shares Outstanding 13.86M 5.023M
Diluted Shares Outstanding 22.03M 19.20M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $35.24M $14.90M
YoY Change 136.53% 7350.0%
Cash & Equivalents $35.24M $14.92M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $35.24M $14.90M
YoY Change 136.53% 7350.0%
LONG-TERM ASSETS
Property, Plant & Equipment $61.35M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $7.588B $5.782B
YoY Change 31.23% 115.22%
Other Assets $180.0K $600.0K
YoY Change -70.0%
Total Long-Term Assets $7.986B $5.945B
YoY Change 34.33% 118.97%
TOTAL ASSETS
Total Short-Term Assets $35.24M $14.90M
Total Long-Term Assets $7.986B $5.945B
Total Assets $8.021B $5.960B
YoY Change 34.58% 119.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.492M $3.800M
YoY Change 70.84% 137.5%
Accrued Expenses $7.696M $2.800M
YoY Change 174.86% 211.11%
Deferred Revenue
YoY Change
Short-Term Debt $297.0M $162.2M
YoY Change 83.1%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $311.2M $168.8M
YoY Change 84.35% 6652.0%
LONG-TERM LIABILITIES
Long-Term Debt $7.202B $5.372B
YoY Change 34.07% 124.16%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $7.202B $5.372B
YoY Change 34.07% 124.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $311.2M $168.8M
Total Long-Term Liabilities $7.202B $5.372B
Total Liabilities $7.513B $5.540B
YoY Change 35.6% 130.96%
SHAREHOLDERS EQUITY
Retained Earnings $33.77M $9.218M
YoY Change 266.31% -222.74%
Common Stock $338.3M $137.9M
YoY Change 145.31% 49.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares $287.0K
Shareholders Equity $359.3M $134.4M
YoY Change
Total Liabilities & Shareholders Equity $8.021B $5.960B
YoY Change 34.58% 119.5%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $18.74M $25.07M
YoY Change -25.26% -494.62%
Depreciation, Depletion And Amortization $944.0K $0.00
YoY Change
Cash From Operating Activities $38.51M $9.076M
YoY Change 324.32% 76.4%
INVESTING ACTIVITIES
Capital Expenditures $184.6M
YoY Change
Acquisitions
YoY Change
Other Investing Activities $211.1M $71.41M
YoY Change 195.62% 130.8%
Cash From Investing Activities $211.1M $71.41M
YoY Change 195.63% 130.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $113.5M $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$247.4M -$98.47M
YoY Change 151.27% 174.41%
NET CHANGE
Cash From Operating Activities $38.51M $9.076M
Cash From Investing Activities $211.1M $71.41M
Cash From Financing Activities -$247.4M -$98.47M
Net Change In Cash $2.191M -$17.98M
YoY Change -112.18% -9228.93%
FREE CASH FLOW
Cash From Operating Activities $38.51M $9.076M
Capital Expenditures $184.6M
Free Cash Flow -$146.0M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P2Y
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35243000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26459000 USD
CY2022Q1 us-gaap Restricted Cash
RestrictedCash
180000 USD
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
6773000 USD
CY2022Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
13433000 USD
CY2021Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
0 USD
CY2022Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
61346000 USD
CY2021Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
62269000 USD
CY2022Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
311630000 USD
CY2021Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
241517000 USD
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
58789000 USD
CY2021Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
58460000 USD
CY2022Q1 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
744525000 USD
CY2021Q4 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
847364000 USD
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2000000
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1645000
CY2022Q1 us-gaap Nontrade Receivables
NontradeReceivables
10231000 USD
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1645000
CY2021Q4 us-gaap Nontrade Receivables
NontradeReceivables
8319000 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Trading Securities Debt
TradingSecuritiesDebt
68133000 USD
CY2021Q4 us-gaap Trading Securities Debt
TradingSecuritiesDebt
69816000 USD
CY2022Q1 nref Accounts Receivable And Other Assets
AccountsReceivableAndOtherAssets
1710000 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 nref Accounts Receivable And Other Assets
AccountsReceivableAndOtherAssets
393000 USD
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q1 us-gaap Assets
Assets
8021455000 USD
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9450921
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14485274
CY2021Q4 us-gaap Assets
Assets
8513917000 USD
CY2022Q1 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
296991000 USD
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9163934
CY2022Q1 us-gaap Treasury Stock Preferred Shares
TreasuryStockPreferredShares
355000
CY2021Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
286324000 USD
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14587514
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Unsecured Debt
UnsecuredDebt
202695000 USD
CY2021Q4 us-gaap Unsecured Debt
UnsecuredDebt
168325000 USD
CY2022Q1 us-gaap Secured Debt
SecuredDebt
32188000 USD
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2000000
CY2021Q4 us-gaap Treasury Stock Preferred Shares
TreasuryStockPreferredShares
355000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14772261
CY2022Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
286987
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
286987
CY2022Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.5313
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.5000
CY2021Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.5313
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4750
CY2021Q4 us-gaap Secured Debt
SecuredDebt
32176000 USD
CY2022Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
58789000 USD
CY2022Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
6492000 USD
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
3903000 USD
CY2022Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
7696000 USD
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
3985000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
7512806000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
8007211000 USD
CY2022Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
149262000 USD
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
261423000 USD
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
16000 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
16000 USD
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
145000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
92000 USD
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
338127000 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
222300000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
33766000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
28367000 USD
CY2022Q1 us-gaap Treasury Stock Preferred Value
TreasuryStockPreferredValue
8567000 USD
CY2021Q4 us-gaap Treasury Stock Preferred Value
TreasuryStockPreferredValue
8567000 USD
CY2022Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
4195000 USD
CY2021Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
4195000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
359387000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
245283000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8021455000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8513917000 USD
CY2022Q1 us-gaap Interest Income Operating
InterestIncomeOperating
31973000 USD
CY2021Q1 us-gaap Interest Income Operating
InterestIncomeOperating
12649000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
8818000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
6497000 USD
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
23155000 USD
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6152000 USD
CY2022Q1 us-gaap Debt Securities Trading Unrealized Gain Loss
DebtSecuritiesTradingUnrealizedGainLoss
-4340000 USD
CY2021Q1 us-gaap Debt Securities Trading Unrealized Gain Loss
DebtSecuritiesTradingUnrealizedGainLoss
631000 USD
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
329000 USD
CY2021Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
834000 USD
CY2022Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
151000 USD
CY2021Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
124000 USD
CY2022Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0 USD
CY2021Q1 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-65000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
173000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
303000 USD
CY2022Q1 us-gaap Net Income Loss From Real Estate Investment Partnership
NetIncomeLossFromRealEstateInvestmentPartnership
-213000 USD
CY2021Q1 us-gaap Net Income Loss From Real Estate Investment Partnership
NetIncomeLossFromRealEstateInvestmentPartnership
0 USD
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-786000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22290000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1763000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1518000 USD
CY2022Q1 us-gaap Loan Portfolio Expense
LoanPortfolioExpense
1141000 USD
CY2021Q1 us-gaap Loan Portfolio Expense
LoanPortfolioExpense
1336000 USD
CY2022Q1 us-gaap Management Fee Expense
ManagementFeeExpense
728000 USD
CY2021Q1 us-gaap Management Fee Expense
ManagementFeeExpense
518000 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
3632000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
3372000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
18737000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
25070000 USD
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
874000 USD
CY2021Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
874000 USD
CY2022Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
4943000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
15829000 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12920000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8367000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13855000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5023000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22030000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19199000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.67
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.26
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.5000
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4750
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
245283000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
533000 USD
CY2022Q1 nref Stock Issued During Period Value Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodValueConversionOfRedeemableNoncontrollingInterests
113535000 USD
CY2022Q1 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
7175000 USD
CY2022Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
874000 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12920000 USD
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
874000 USD
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
7521000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
359387000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
128243000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
391000 USD
CY2021Q1 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
-0 USD
CY2021Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
874000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8367000 USD
CY2021Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
874000 USD
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
2634000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
134367000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
18737000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
25070000 USD
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
9900000 USD
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2516000 USD
CY2022Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
3030000 USD
CY2021Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1668000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
944000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 USD
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
12000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
CY2022Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
151000 USD
CY2021Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
124000 USD
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-8545000 USD
CY2021Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
16476000 USD
CY2022Q1 nref Realized Investment Gains Losses Net
RealizedInvestmentGainsLossesNet
-0 USD
CY2021Q1 nref Realized Investment Gains Losses Net
RealizedInvestmentGainsLossesNet
-65000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
673000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
391000 USD
CY2022Q1 nref Payment Inkind
PaymentInkind
168000 USD
CY2021Q1 nref Payment Inkind
PaymentInkind
-0 USD
CY2022Q1 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
1912000 USD
CY2021Q1 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
568000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
1317000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
2639000 USD
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
3711000 USD
CY2021Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
480000 USD
CY2022Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
2265000 USD
CY2021Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1781000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38511000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9076000 USD
CY2022Q1 us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
124633000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
834000 USD
CY2022Q1 nref Payments To Acquire Bridge Loan
PaymentsToAcquireBridgeLoan
13433000 USD
CY2021Q1 nref Payments To Acquire Bridge Loan
PaymentsToAcquireBridgeLoan
-0 USD
CY2022Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
99708000 USD
CY2021Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
25876000 USD
CY2022Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
4543000 USD
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
-0 USD
CY2022Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
21000 USD
CY2021Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
-0 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
211105000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
71409000 USD
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
86410000 USD
CY2021Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
766000 USD
CY2022Q1 nref Proceeds From Securities Sold Under Agreements To Repurchase
ProceedsFromSecuritiesSoldUnderAgreementsToRepurchase
25141000 USD
CY2021Q1 nref Proceeds From Securities Sold Under Agreements To Repurchase
ProceedsFromSecuritiesSoldUnderAgreementsToRepurchase
5737000 USD
CY2022Q1 nref Payments For Securities Sold Under Agreements To Repurchase
PaymentsForSecuritiesSoldUnderAgreementsToRepurchase
14474000 USD
CY2021Q1 nref Payments For Securities Sold Under Agreements To Repurchase
PaymentsForSecuritiesSoldUnderAgreementsToRepurchase
5034000 USD
CY2022Q1 us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
34173000 USD
CY2021Q1 us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
0 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
113535000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2022Q1 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
113535000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
-0 USD
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
140000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
-0 USD
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
7197000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2386000 USD
CY2022Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
874000 USD
CY2021Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
874000 USD
CY2022Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
3569000 USD
CY2021Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
5912000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-247425000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-98469000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2191000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-17984000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33232000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33471000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
35423000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15487000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
4910000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
7289000 USD
CY2022Q1 nref Increase Decrease In Dividends Payable Upon Vesting Of Restricted Stock Units
IncreaseDecreaseInDividendsPayableUponVestingOfRestrictedStockUnits
324000 USD
CY2021Q1 nref Increase Decrease In Dividends Payable Upon Vesting Of Restricted Stock Units
IncreaseDecreaseInDividendsPayableUponVestingOfRestrictedStockUnits
248000 USD
CY2022Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 USD
CY2021Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
874000 USD
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Use of Estimates and Assumptions</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:25pt;">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. It is at least reasonably possible that these estimates could change in the near term. Estimates are inherently subjective in nature and actual results could differ from our estimates and the differences could be material.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:25pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:25pt;">As a result of the COVID-<em style="font: inherit;">19</em> pandemic, the Company has received and <em style="font: inherit;"> may </em>continue to receive forbearance requests and <em style="font: inherit;"> may </em>experience difficulty making new investments or redeploying proceeds from repayments of our existing investments, meeting financial covenants in the Company's debt obligations or accessing debt and equity capital on attractive terms, or at all. In addition, reduced economic activity <em style="font: inherit;"> may </em>cause certain borrowers underlying the Company’s real estate related assets and senior loans to become delinquent or default on their loans, or seek to defer payment on, or refinance, their loans. The Company is closely monitoring the impact of the COVID-<em style="font: inherit;">19</em> pandemic on all aspects of our business. From inception through <em style="font: inherit;"> March 31, 2022</em>, there have been four forbearance requests approved in the Company's CMBS B-Piece portfolio, representing 0.8% of the Company's consolidated unpaid principal balance outstanding. Additionally, there were nine forbearance requests approved in the Company's SFR Loan book. However, as of <em style="font: inherit;"> March 31, 2022</em>, these loans were <em style="font: inherit;">no</em> longer in forbearance. Despite these forbearance requests, the master servicers continued to make payments to the Company for the portion of our CMBS B-Piece and SFR Loans that requested forbearance, and were approved by the Federal Home Loan Mortgage Corporation (“Freddie Mac”), during the entire forbearance period. The payments made by master servicers during the forbearance period included both principal and interest payments for <em style="font: inherit;">three</em> months, and the forbearance agreement granted an option to the borrower to extend the forbearance period for an additional <em style="font: inherit;">three</em> months and required the borrower to repay Freddie Mac within <em style="font: inherit;">twelve</em> months of the end of the forbearance period. For additional information regarding the risks to the Company related to the COVID-<em style="font: inherit;">19</em> pandemic, or any other future pandemic, see "Item <em style="font: inherit;">1A.</em> Risk Factors" of our Annual Report on Form <em style="font: inherit;">10</em>-K filed with the SEC on <em style="font: inherit;"> February 28, 2022.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q4 nref Loans And Leases Receivable Weighted Average Coupon
LoansAndLeasesReceivableWeightedAverageCoupon
0.0577 pure
CY2021 nref Loans And Leases Receivable Weighted Average Life
LoansAndLeasesReceivableWeightedAverageLife
P6Y2M12D
CY2022Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2022Q1 nref Loans And Preferred Equity Gross
LoansAndPreferredEquityGross
1010076000 USD
CY2022Q1 nref Loans And Preferred Equity Net Amount
LoansAndPreferredEquityNetAmount
1056155000 USD
CY2022Q1 nref Loans And Leases Receivable Number Of Loans
LoansAndLeasesReceivableNumberOfLoans
47 pure
CY2022Q1 nref Loans And Leases Receivable Weighted Average Fixed Rate
LoansAndLeasesReceivableWeightedAverageFixedRate
0.9552 pure
CY2022Q1 nref Loans And Leases Receivable Weighted Average Coupon
LoansAndLeasesReceivableWeightedAverageCoupon
0.0623 pure
CY2022Q1 nref Loans And Leases Receivable Weighted Average Life
LoansAndLeasesReceivableWeightedAverageLife
P5Y10M24D
CY2021Q4 nref Loans And Preferred Equity Gross
LoansAndPreferredEquityGross
1034542000 USD
CY2021Q4 nref Loans And Preferred Equity Net Amount
LoansAndPreferredEquityNetAmount
1088881000 USD
CY2021Q4 nref Loans And Leases Receivable Number Of Loans
LoansAndLeasesReceivableNumberOfLoans
51 pure
CY2021Q4 nref Loans And Leases Receivable Weighted Average Fixed Rate
LoansAndLeasesReceivableWeightedAverageFixedRate
0.9548 pure
CY2022Q1 nref Paidinkind Distribution Reinvested In Preferred Units
PaidinkindDistributionReinvestedInPreferredUnits
168000 USD
CY2021Q1 nref Paidinkind Distribution Reinvested In Preferred Units
PaidinkindDistributionReinvestedInPreferredUnits
0 USD
CY2022Q1 nref Mortgage Loans On Real Estate Provision On Loan Loss
MortgageLoansOnRealEstateProvisionOnLoanLoss
-151000 USD
CY2021Q1 nref Mortgage Loans On Real Estate Provision On Loan Loss
MortgageLoansOnRealEstateProvisionOnLoanLoss
-124000 USD
CY2021Q4 us-gaap Financing Receivable Unamortized Purchase Premium Discount
FinancingReceivableUnamortizedPurchasePremiumDiscount
55000000.0 USD
CY2022Q1 nref Loans And Leases Receivable Number Of Loans
LoansAndLeasesReceivableNumberOfLoans
47 pure
CY2022Q1 nref Loans And Preferred Equity Net Amount
LoansAndPreferredEquityNetAmount
1056155000 USD
CY2022Q1 nref Loans And Leases Receivable Percentage Of Loan Portfolio
LoansAndLeasesReceivablePercentageOfLoanPortfolio
1.0000 pure
CY2021Q4 nref Loans And Leases Receivable Number Of Loans
LoansAndLeasesReceivableNumberOfLoans
51 pure
CY2021Q4 nref Loans And Preferred Equity Net Amount
LoansAndPreferredEquityNetAmount
1088881000 USD
CY2021Q4 nref Loans And Leases Receivable Percentage Of Loan Portfolio
LoansAndLeasesReceivablePercentageOfLoanPortfolio
1.0000 pure
CY2022Q1 nref Loans And Leases Receivable Percentage Of Loan Portfolio
LoansAndLeasesReceivablePercentageOfLoanPortfolio
1.0000 pure
CY2021Q4 nref Loans And Leases Receivable Percentage Of Loan Portfolio
LoansAndLeasesReceivablePercentageOfLoanPortfolio
1.0000 pure
CY2022Q1 nref Loans And Leases Receivable Percentage Of Loan Portfolio
LoansAndLeasesReceivablePercentageOfLoanPortfolio
1.0000 pure
CY2021Q4 nref Loans And Leases Receivable Percentage Of Loan Portfolio
LoansAndLeasesReceivablePercentageOfLoanPortfolio
1.0000 pure
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4800000 USD
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
14.61
CY2021Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
40435
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
286987
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
296991000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
4830000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
5690000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
82594000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
211764000 USD
CY2022Q1 nref Longterm Debt Maturity After Year Four
LongtermDebtMaturityAfterYearFour
633918000 USD
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
1235787000 USD
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
327422
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14772261
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14485274
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
10000000.0 USD
CY2021Q3 nref Stock Issuance Agreement Number Of Shares
StockIssuanceAgreementNumberOfShares
13578905.9
CY2021Q3 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
1479132
CY2021Q3 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
1479132
CY2021Q1 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
15829000 USD
CY2022Q1 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
113535000 USD
CY2021Q1 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
-0 USD
CY2022Q1 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
4774572
CY2022Q1 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
4774570
CY2022Q1 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
395033
CY2022Q1 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
395033
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12920000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8367000 USD
CY2022Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
4943000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
15829000 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
17863000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
24196000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13855000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5023000
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
525000
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
389000
CY2022Q1 nref Incremental Common Shares Attributable To Dilutive Effect Of Op Units And Sub Op Units
IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnitsAndSubOPUnits
7650000
CY2021Q1 nref Incremental Common Shares Attributable To Dilutive Effect Of Op Units And Sub Op Units
IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnitsAndSubOPUnits
13787000
CY2022Q1 nref Weighted Average Number Of Diluted Shares Outstanding Including Op Unit Effect
WeightedAverageNumberOfDilutedSharesOutstandingIncludingOpUnitEffect
22030000
CY2021Q1 nref Weighted Average Number Of Diluted Shares Outstanding Including Op Unit Effect
WeightedAverageNumberOfDilutedSharesOutstandingIncludingOpUnitEffect
19199000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.67
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.26
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
261423000 USD
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
275670000 USD
CY2022Q1 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
4943000 USD
CY2022Q1 nref Distributions To Redeemable Noncontrolling Interests On Operating Partnership
DistributionsToRedeemableNoncontrollingInterestsOnOperatingPartnership
3569000 USD
CY2021Q1 nref Distributions To Redeemable Noncontrolling Interests On Operating Partnership
DistributionsToRedeemableNoncontrollingInterestsOnOperatingPartnership
5912000 USD
CY2022Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
149262000 USD
CY2021Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
285587000 USD
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14485274
CY2022Q1 us-gaap Payment For Management Fee
PaymentForManagementFee
0 USD
CY2021Q4 nref Stock Issuance Agreement Number Of Shares
StockIssuanceAgreementNumberOfShares
13758905.9
CY2021Q3 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
1479132
CY2021Q3 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
1479132
CY2022Q1 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
4774572
CY2022Q1 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
4774570
CY2022Q1 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
395033
CY2022Q1 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
395033
CY2021Q3 nref Purchase Of Preferred Equity Purchase Amount
PurchaseOfPreferredEquityPurchaseAmount
50000000.0 USD
CY2021Q3 nref Purchase Of Preferred Equity Purchase Amount Option
PurchaseOfPreferredEquityPurchaseAmountOption
25000000.0 USD
CY2021Q3 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
3000000.0 USD
CY2021Q4 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
30000000.0 USD
CY2021Q4 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
3800000 USD
CY2022Q1 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
900000 USD
CY2022Q1 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
200000 USD
CY2022Q1 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
18500000 USD
CY2022Q1 nref Purchase Of Preferred Equity Purchase Amount Option
PurchaseOfPreferredEquityPurchaseAmountOption
18600000 USD
CY2021Q3 nref Preferred Units Distribution Rate
PreferredUnitsDistributionRate
0.100 pure

Files In Submission

Name View Source Status
0001437749-22-010537-index-headers.html Edgar Link pending
0001437749-22-010537-index.html Edgar Link pending
0001437749-22-010537.txt Edgar Link pending
0001437749-22-010537-xbrl.zip Edgar Link pending
ex_348656.htm Edgar Link pending
ex_348657.htm Edgar Link pending
ex_348658.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nref-20220331.xsd Edgar Link pending
nref-20220331_cal.xml Edgar Link unprocessable
nref-20220331_def.xml Edgar Link unprocessable
nref-20220331_lab.xml Edgar Link unprocessable
nref-20220331_pre.xml Edgar Link unprocessable
nref20220331_10q.htm Edgar Link pending
nref20220331_10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending